Evidence map›Paper›PMID 37258853›Full record

ArticleJournal of epidemiology and global health2023

The Role of "Hierarchical and Classified Prevention and Control Measures (HCPC)" Strategy for SARS-CoV-2 Delta Variant in Guangzhou: A Modeling Study.

Yu Ma, Hui Wang, Yong Huang, Chun Chen, Shihao Liang, Mengmeng Ma, Xinjun He, Kangning Cai, Zengtao Jiao, Liyi Chen and 5 more

Abstract read
In one paragraph

Article in Journal of epidemiology and global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yu MaGuangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China.
Hui WangGuangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China.
Yong HuangGuangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China.
Chun ChenGuangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China.
Shihao LiangYidu Cloud (Beijing) Technology Co.Ltd, Beijing, 100083, People's Republic of China.
Mengmeng MaGuangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China.
Xinjun HeYidu Cloud (Beijing) Technology Co.Ltd, Beijing, 100083, People's Republic of China.
Kangning CaiYidu Cloud (Beijing) Technology Co.Ltd, Beijing, 100083, People's Republic of China.
Zengtao JiaoYidu Cloud (Beijing) Technology Co.Ltd, Beijing, 100083, People's Republic of China.
Liyi ChenYidu Cloud (Beijing) Technology Co.Ltd, Beijing, 100083, People's Republic of China.
Bowei ZhuYidu Cloud (Beijing) Technology Co.Ltd, Beijing, 100083, People's Republic of China.
Ke LiGuangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China.
Chaojun XieGuangzhou Huadu District Center for Disease Control and Prevention, Guangzhou, China.
Lei LuoGuangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China. 1017225735@qq.com.
Zhoubin ZhangGuangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510120, People's Republic of China. gzcdczzb@gzcdc.org.cn.

Funding

General Guidance Project of Guangzhou Health and Family Planning Technology 20181A011050Guangzhou Basic Research Plan City School (Institute) Enterprise Joint Funding Project 2023A03J0454the Key Project of Medicine Discipline of Guangzhou 2021-2023-11
6 · The paper itself

Abstract

backgroundThe Delta variant of SARS-COV-2 has replaced previously circulating strains around the world in 2021. Sporadic outbreaks of the Delta variant in China have posed a concern about how to properly respond to the battle against evolving COVID-19. Here, we analyzed the "hierarchical and classified prevention and control (HCPC)" measures strategy deployed during the recent Guangzhou outbreak.

methodsA modified susceptible-exposed-pre-symptomatic-infectious-recovered (SEPIR) model was developed and applied to study a range of different scenarios to evaluate the effectiveness of policy deployment. We simulated severe different scenarios to understand policy implementation and timing of implementation. Two outcomes were measured: magnitude of transmission and duration of transmission. The outcomes of scenario evaluations were presented relative to the reality case (i.e., 368 cases in 34 days) with 95% confidence interval (CI).

resultsBased on our simulation, the outbreak would become out of control with 7 million estimated infections under the assumption of the absence of any interventions than the 153 reported cases in reality in Guangzhou. The simulation on delayed implementation of interventions showed that the total case numbers would also increase by 166.67%-813.07% if the interventions were delayed by 3 days or 7 days.

conclusionsIt may be concluded that timely and more precise interventions including mass testing and graded community management are effective measures for Delta variant containment in China.

Indexed as

COVID-19SARS-CoV-2ChinaDisease OutbreaksHumansCOVID-19Model simulationNon-pharmaceutical interventionSARS-CoV-2

Identifiers

PMID37258853
PMCPMC10231852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.